학술논문
MGTA-145, in Combination with Plerixafor in a Phase 1 Clinical Study, Mobilizes Large Numbers of Hematopoietic Stem Cells and a Graft with Potent Immunosuppressive Properties for Autologous and Allogeneic Transplant
Document Type
Article
Author
Source
Transplantation and Cellular Therapy; March 2021, Vol. 27 Issue: 3, Number 3 Supplement 1 pS34-S34, 1p
Subject
Language
ISSN
26666375; 26666367